Bright Minds Biosciences DRUG Balance Sheet (2019-2026)

NASDAQ DRUG
$67.60 -0.42 (-0.62%)
As of: Sep 4, 2026 · 12:42 PM EDT
Reported Financials

Bright Minds Biosciences Quarterly Balance Sheet

Periods 25 quarters
Latest Jun 2026

Bright Minds Biosciences reported total assets of $224.35M and total liabilities of $1.84M for the quarter ended Jun 2026, up 492.1% year over year. This balance sheet covers 25 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
15.70M11.99M9.05M6.78M8.92M8.26M7.15M6.05M5.03M4.97M4.40M4.53M4.19M41.45M38.80M37.09M60.24M63.86M225.83M222.54M
Cash & Current Investments
15.70M11.99M9.05M6.78M8.92M8.26M7.15M6.05M5.03M4.97M4.40M4.53M4.19M41.45M38.80M37.09M60.24M63.86M225.83M222.54M
Receivables - OtherOther Receivables
-0.03M0.03M0.03M0.03M0.03M0.40M0.12M0.11M
Prepaid Assets
0.13M0.11M0.07M0.06M0.13M0.12M0.13M0.11M0.02M0.02M0.01M0.04M0.16M0.18M0.28M0.51M0.72M0.89M1.07M0.98M
Current Assets
15.92M9.16M8.42M7.31M6.24M5.08M5.02M4.82M4.58M4.39M41.68M39.25M37.80M61.26M65.10M227.73M224.31M
Non-Current Assets
Long-Term Investments
0.07M0.07M0.07M0.07M0.07M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.12M0.13M0.12M
Intangibles
0.00M0.00M0.00M0.00M
Goodwill & Intangibles
0.00M0.00M0.00M0.00M
Non-Current Assets
0.00M0.11M0.09M0.08M0.06M0.05M0.04M0.02M0.01M0.09M0.13M0.11M0.09M0.08M0.07M0.05M0.04M
Assets
15.92M12.23M9.29M6.92M9.27M8.51M7.39M6.30M5.13M5.06M4.85M4.59M4.47M41.80M39.35M37.89M61.34M65.17M227.78M224.35M
Liabilities
Current Liabilities
Accounts Payables
0.51M0.39M0.79M0.30M1.08M0.34M0.69M0.48M0.59M0.60M0.12M0.33M0.28M0.39M0.38M1.64M1.07M2.73M1.79M
Payables
0.51M0.39M0.79M0.30M1.08M0.34M0.69M0.48M0.59M0.60M0.12M0.33M0.28M0.39M0.38M1.64M1.07M2.73M1.79M
Current Leases
0.05M0.05M0.05M0.06M0.05M0.04M0.03M0.01M0.06M0.05M0.05M0.06M0.06M0.06M0.06M0.05M
Total Current Liabilities
0.51M1.13M0.39M0.74M0.54M0.21M0.39M0.33M0.44M0.44M1.70M1.13M2.79M1.84M
Non-Current Liabilities
Operating Leases
0.11M0.04M0.03M0.01M0.03M0.08M0.06M0.05M0.03M0.01M
Other Non-Current Liabilities
0.01M0.61M0.62M0.62M0.62M0.61M0.62M0.61M0.33M
Total Non-Current Liabilities
0.29M1.18M-0.18M0.15M-0.07M-0.41M0.02M0.01M-0.48M0.08M1.73M
Total Liabilities
0.51M0.39M0.79M0.30M1.18M0.43M0.77M0.55M0.21M0.63M0.63M0.13M0.42M0.41M0.51M0.48M1.73M1.15M2.79M1.84M
Shareholder's Equity
Common Equity
15.41M11.84M8.49M6.62M8.08M8.08M6.62M5.75M4.92M4.43M4.22M4.46M4.06M41.40M38.85M37.41M59.62M64.02M224.98M222.51M
Liabilities and Shareholders Equity
15.92M12.23M9.29M6.92M9.27M8.51M7.39M6.30M5.13M5.06M4.85M4.59M4.47M41.80M39.35M37.89M61.34M65.17M227.78M224.35M
Retained Earnings
-7.32M-11.16M-14.65M-16.64M18.54M-19.53M-21.13M-22.35M23.53M-24.41M-25.09M-24.55M-25.18M-24.55M-25.96M-30.67M33.85M-38.83M-47.11M-48.44M